Effect of Gender Affirming Hormone Therapy on Glucose Metabolism

NCT04515472 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

24

Enrollment

OTHER

Sponsor class

Stopped VA policy released 3/17/25 to phase out treatment for gender dysphoria

Conditions

Transgender Persons

Interventions

DRUG: Botnia Clamp
OTHER: Withdrawal of Gender Affirming Hormone Therapy (GAHT)

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]